Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
C HasselmannF Labarthe

Abstract

The Diabetes Control and Complications Trial clearly demonstrated the benefits of blood glucose control, especially in children and adolescents, in the prevention of long-term complications of type 1 diabetes (T1D). This can be achieved with intensive insulin treatment with either multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII), also known as insulin pump. The aim of this study was to compare glycemic control of T1D children treated with either CSII or MDI. Thirty-eight T1D children treated with CSII were compared to 38 children treated with MDI, matched for age, gender, and duration of diabetes. Collected data, including daily doses of insulin in IU/kg/d, HbA1c levels, body mass index expressed in standard deviation/age, number of severe hypoglycemia episodes and of admissions related to T1D expressed in events/patient/year, were retrospectively collected every 3 months. There was no difference between the 2 groups at baseline. During the 3 years of follow-up, patients treated with CSII had lower daily doses of insulin (0.78 ± 0.19 vs. 0.87 ± 0.22 IU/kg/d, p<0.05), significantly lower levels of HbA1c (7.5 ± 0.6 vs. 8.0 ± 1.3 %, p<0.05), and a decreased number of admissions related to ...Continue Reading

References

May 17, 2002·Journal of Pediatric Endocrinology & Metabolism : JPEM·K RaileH P Schwarz
Sep 3, 2004·The Journal of Pediatrics·Linda A DiMeglioErica A Eugster
Oct 27, 2006·Diabetes Care·Jamie R WoodLori M B Laffel
Jan 18, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·B I JakischUNKNOWN German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy
Jun 23, 2009·Diabetes Research and Clinical Practice·Mariola Minkina-PedrasEwa Malecka-Tendera
Aug 4, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·E Müller-GodeffroyUNKNOWN German Working Group for Paediatric Pump Therapy
Sep 17, 2009·Pediatric Diabetes·Joseph WolfsdorfRagnar Hanas
Jun 4, 2010·Diabetes Care·Ragnar HanasUNKNOWN International HBA1c Consensus Committee
Jul 1, 2010·The New England Journal of Medicine·Richard M BergenstalUNKNOWN STAR 3 Study Group
Nov 27, 2010·Archives of Disease in Childhood·C R HughesC Costigan
Dec 9, 2010·European Journal of Pediatrics·Włodzimierz ŁuczyńskiArtur Bossowski
Sep 22, 2011·Diabetes Care·Richard M BergenstalUNKNOWN STAR 3 Study Group

❮ Previous
Next ❯

Citations

Jul 9, 2016·Pediatric Diabetes·Kevin KaisermanMyriam Rosilio
Feb 2, 2016·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Maria Estela Bellini RibeiroCarlos Eduardo Martinelli Junior

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.